Two concurrent outbreaks of hepatitis A highlight the risk of infection for non-immune travellers to Morocco, January to June 2018M Gassowski, K Michaelis, JJ Wenzel, M Faber, J Figoni, I Mouna, IH Friesema, H Vennema, A Avellon, C Varela, et al.16/07/2018Tijdschriftartikel
The Effectiveness and Cost-Effectiveness of Hepatitis C Screening for Migrants in the EU/EEA: A Systematic ReviewC Greenaway, I Makarenko, CNA Chakra, B Alabdulkarim, R Christensen, I Veldhuijzen, al et2018-09-24Tijdschriftartikel
Cardiovascular risk model performance in women with and without hypertensive disorders of pregnancyV Dam, NC Onland-Moret, WMM Verschuren, JMA Boer, L Benschop, al et17-09-2018Tijdschriftartikel
Initiation of anti-retroviral therapy before pregnancy reduces the risk of infection-related hospitalization in HIV-exposed uninfected infants born in a high-income countryT Goetghebuer, KK Smolen, C Adler, J Das, T McBride, G Smits, F van der Klis, al et17-09-2018Tijdschriftartikel
Microscopic examination of Gram-stained smears for anogenital gonorrhoea in men who have sex with men is cost-effective: evidence from a modelling studyJM Zwart, MJ Mangen, M Bartelsman, MS van Rooijen, HJC de Vries, M Xiridou2018-09-17Tijdschriftartikel
Diverse tick-borne microorganisms identified in free-living ungulates in SlovakiaM Kazimirova, Z Hamsikova, E Spitalska, L Minichova, L Mahrikova, H Sprong, M Fonville, et al.10/09/2018Tijdschriftartikel
Trends and determinants of antimicrobial susceptibility of Neisseria gonorrhoeae in the Netherlands, 2007 to 2015SH Hofstraat, HM Götz, AP van Dam, MA van der Sande, BH van Benthem17/09/2018Tijdschriftartikel
Screening and prevention of infectious diseases in newly arrived migrants. Integrating hepatitis B, hepatitis C and HIV screening into tuberculosis entry screening for migrants in the Netherlands, 2013 to 2015JP Bil, PAG Schrooders, M Prins, PM Kouw, JHE Klomp, M Scholing, LPHM Huijbregts, GJB Sonder, CHFM Waegemaekers, HJC de Vries, W Meijer, FR Zuure, A Tostmann16/04/2018Tijdschriftartikel
Updated cost-effectiveness and risk-benefit analysis of two infant rotavirus vaccination strategies in a high-income, low-endemic settingP Bruijning-Verhagen, JAP van Dongen, JDM Verberk, R Pijnacker, RD van Gaalen, D Klinkenberg, HE de Melker, MJJ Mangen17/09/2018Tijdschriftartikel